Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood cancer
Biotech
AbbVie sues BeiGene over blood cancer drug trade secrets
After scoring an FDA Fast Track tag for its BTK degrader candidate, BeiGene has been accused of trade secrets theft by its old oncology rival AbbVie.
Fraiser Kansteiner
Sep 11, 2024 10:17am
FDA rejects Regeneron bispecific, delaying rival to J&J, Pfizer
Aug 21, 2024 5:48am
FDA hands de novo clearance to Scopio's bone marrow pathology AI
Apr 17, 2024 12:56pm
AACR: Regeneron's multiple myeloma drug shows staying power
Apr 7, 2024 4:00pm
Regeneron seeks clarity on confirmatory trials after FDA hurdle
Mar 29, 2024 5:00am
Geron secures 12-2 AdComm vote in favor of blood cancer drug
Mar 15, 2024 5:00am
